Antitumor agent-58

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Antitumor agent-58 

Antitumor agent-58 (Compound C18) 是一种抗肿瘤剂。Antitumor agent-58 有效抑制 MGC-803 细胞的集落形成和细胞迁移。Antitumor agent-58 通过激活 p38 和 JNK 信号通路诱导 MGC-803 细胞凋亡 (apoptosis)。Antitumor agent-58 诱导 MGC-803 细胞的线粒体功能障碍。Antitumor agent-58 有效抑制携带 MGC-803 细胞的异种移植模型的肿瘤生长。

Antitumor agent-58

Antitumor agent-58 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Antitumor agent-58 (Compound C18) is an anti-tumor agent. Antitumor agent-58 effectively inhibits colony formation and cell migration of MGC-803 cells. Antitumor agent-58 induces apoptosis of MGC-803 cells through activation of the p38 and JNK signaling pathways. Antitumor agent-58 induces mitochondrial dysfunction of MGC-803 cells. Antitumor agent-58 effectively inhibits tumor growth of xenograft model bearing MGC-803 cells[1].

分子量

567.63

Formula

C27H28F3N9S
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Shi XJ, et al. Discovery of tofacitinib derivatives as orally active antitumor agents based on the scaffold hybridization strategy. Eur J Med Chem. 2020 Oct 1;203:112601.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务